CheckMate 9ER: What Is the Impact for RCC?
A roundtable discussion, moderated by Rana McKay, MD, discussed the latest updates in frontline treatment for renal cell carcinoma, including how data from the American Society of Clinical Oncology Genitourinary Cancers Symposium 2024 alters the treatment paradigm. Dr. McKay was joined by Nizar Tannir, MD; Hans Hammers, MD; and Katy Beckermann, MD. In the fifth segment of the roundtable series, the panel highlighted the CheckMate 9ER study and implications for clinical practice.
▶︎
Panel Discussion on OS Data From KEYNOTE-564 Study and Post-Relapse Treatment Selection
▶︎
Expert Panel Shares Forward-Looking Thoughts on RCC Treatment, Clinical Trials
▶︎
The best foods to fight inflammation this spring | Prof. Tim Spector and Dr. Federica Amati
▶︎
This Common Food Is Feeding Your Cancer Cells - Dr. William Li
▶︎
CheckMate 9ER Trial Demonstrates Efficacy in Patients With RCC
▶︎
Argentinien – Österreich Highlights | Gruppe J, FIFA WM 2026 | sportstudio
▶︎
10 “Dream” Home Features That FAIL In Real Life
▶︎
How Will EV, Pembrolizumab Combination Change the Bladder Cancer Treatment Landscape?
▶︎
Exposing the LIES of the 20th Century | Aaron Bastani Meets Tariq Ali
▶︎
9 Newly Discovered Signs of ADHD
▶︎
ASCO 2026: Key Insights In Renal Cell Carcinoma, Merkel Cell Carcinoma, and Chronic Myeloid Leukemia
▶︎
How To Change Your Eye Shape With Makeup? | Elena Rachitskaya
▶︎
Why Luxury Prisons are Actually Genius
▶︎
THE SNEAKY EYELINER TRICK FOR MATURE WOMEN | Nikol Johnson
▶︎
Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions
▶︎
Episode 1: Are We Ready for Biology Driven Bladder Cancer Care
▶︎
Dr K Meets 20 Depressed Patients! Therapist Reacts
▶︎
Navigating CRPC: PARP Inhibitors, Radioligands, and Sequencing Strategies
▶︎
Knochenbrechen für die perfekte Jawline – Wie weit geht Looksmaxxing? I Y-Kollektiv
▶︎